JENNIFER GIBSON: Open Payments
NPI 1740877893 · PORT NECHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 41 payments from 15 companies in 2025. Trend: 2023 $663 · 2024 $880 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $134 |
| AstraZeneca Pharmaceuticals LP | 1 | $104 |
| Inspire Medical Systems, Inc. | 3 | $92 |
| Novo Nordisk Inc | 5 | $92 |
| PFIZER INC. | 5 | $86 |
| ABBVIE INC. | 4 | $85 |
| Dexcom, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $70 |
| Antares Pharma, Inc. | 3 | $54 |
| Corcept Therapeutics | 1 | $22 |
Products named: Kerendia, AIRSUPRA, INSPIRE, Dexcom G6 Transmitter, Wegovy, NURTEC ODT, XYOSTED, QULIPTA.
Industry payments across TX — which companies pay providers there.
